Keyphrases
Induced Apoptosis
100%
Cell Proliferation
100%
Serotonin 5-HT
100%
5-HT1B Receptor
100%
Proliferation Apoptosis
100%
Selective Serotonin
100%
Uterine Leiomyoma Cell
100%
Cell Survival
60%
Cell-to-cell
40%
5-HT1B
40%
Uterine Leiomyoma
40%
Definitive Treatment
20%
Apoptosis Induction
20%
Quality of Life
20%
Mitogen-activated Protein Kinase
20%
Cell Apoptosis
20%
Tumor
20%
Health Care Costs
20%
Potential Therapeutics
20%
Western Blot Analysis
20%
Serotonin Receptors
20%
Inhibition Mechanism
20%
Kinase Cascade
20%
Cyclin D1 (CCND1)
20%
α-smooth muscle Actin (α-SMA)
20%
Impact on Healthcare
20%
Blockage
20%
Medical Treatment
20%
Apoptotic Cell Death
20%
Cell Reduction
20%
Caspase-8
20%
Leiomyoma
20%
Colony Formation
20%
Undesirable Side Effects
20%
Incidence Rate
20%
Annexin V Staining
20%
Negative Impact
20%
Reproductive Capacity
20%
Colony Formation Assay
20%
Myoma
20%
Fibroids
20%
Cell Proliferation Inhibition
20%
Pelvic Tumor
20%
5-HTR
20%
Elongation Factor 2 Kinase
20%
Lifetime Incidence
20%
Medicine and Dentistry
Programmed Cell Death
100%
Cell Proliferation
100%
Receptor
100%
Serotonin
100%
5-HT Receptors
100%
Uterine Fibroid
100%
Cell Survival
28%
Colony Formation
28%
Combination Therapy
14%
Neoplasm
14%
Side Effect
14%
Health Care Cost
14%
Mitogen-Activated Protein Kinase
14%
Quality of Life
14%
Poly ADP Ribose Polymerase
14%
Lifespan
14%
Cyclin D1
14%
Caspase 8
14%
Angioleiomyoma
14%
Serotonin Receptor
14%
Lipocortin 5
14%
Pelvic Tumor
14%
Myoma
14%
Alpha Smooth Muscle Actin
14%
Elongation Factor 2 Kinase
14%
Western Blotting
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Serotonin
100%
Uterus Myoma
100%
Side Effect
14%
Neoplasm
14%
Western Blot
14%
Combination Therapy
14%
Mitogen Activated Protein Kinase
14%
Cyclin D1
14%
Caspase 8
14%
Lipocortin 5
14%
Alpha Smooth Muscle Actin
14%
Leiomyoma
14%
Pelvis Tumor
14%
Myoma
14%
Serotonin 5 Receptor
14%
Elongation Factor 2 Kinase
14%